TGF-β Inhibits IL-2-Induced Tyrosine Phosphorylation and Activation of Jak-1 and Stat 5 in T Lymphocytes

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 175-183

  Bright, John J ^b   Kerr, Lawrence D ^b   Sriram, Subramaniam ^a  

^a Vanderbilt Stallworth Rehabilitation Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; INTERLEUKIN 2; JAK1 PROTEIN, MOUSE; JANUS KINASE 1; MILK PROTEIN; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; APOPTOSIS; ARTICLE; CELL CLONE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; MOUSE; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL DIVISION; CLONE CELLS; DNA-BINDING PROTEINS; DRUG ANTAGONISM; FEMALE; INTERLEUKIN-2; JANUS KINASE 1; MICE; MILK PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031180973     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and R. K. Assoian. 1986. Transforming growth factor-β: biological function and chemical structure. Science 233:532.
2. Rook, A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, M. B. Sporn, D. B. Burlington, H. C. Lane, and A. S. Fauci, 1986, Effects of transforming growth factor-β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916.
3. Kasid, A., G. I. Bell, and E. P. Director. 1988. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors: autocrine inhibition of cellular proliferation and differentiation to immune killer cells. J. Immunol. 141-690.
4. Cuppner, M. C., M. F. Hamou, S. Bodmer, A. Fontana, and N. de Tribolet. 1988. The glioblastoma-derived T-cell suppressor factor/transforming growth fuctor-β2 inhibits the generation of lymphokine activated killer (LAK) cells. Int. J. Cancer 42:562.
5. Fontana, A., K. Frei, S. Bodmer, E. Hoefer, M. H. Schreier, M. A. Palladino, and R. M. Zinkernagel. 1989. Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice. J. Immunol. 143:3230.
6. Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245.
7. Lucas, C., L. N. Bald, B. M. Fendly, M. Mora-Worms, I. S. Figari, E. J. Patzer, and M. A. Palladino. 1990. The autocrine production of transforming growth factor-β1 during lymphocyte activation. J. Immunol. 145:1415.
8. Fontana, A., D. B. Constam, K. Frei, U. Malipiero, and H. W. Pfister. 1992. Modulation of the immune responses by transforming growth factor-β, Int. Arch. Allergy Immunol. 99:1.
9. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
10. Yamamoto, H., M. Hirayama, C. Genyea, and J. Kaplan, 1994. TGF-β mediates natural suppressor activity of IL-2 activated lymphocytes. J. Immunol. 152:3842.
11. Kehrl, J. H., L. M. Wakefield, A. Roberts, B. Jakowlew, S. M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
12. Chantry, D., M. Turner, E. Abney, and M. Feldmann. 1989. Modulation of cytokine production by transforming growth factor-β1. J. Immunol. 142:4295.
13. Fox, F. E., R. J. Capocasale, H. C. Ford, R. J. Lamb, J. S. Moore, and P. C. Nowell. 1992. Transforming growth factor-β inhibits human T cell proliferation through multiple targets. Lymphokine Cytokine Res. 11:299.
14. Santambrogio, L., G. M. Hochwald, B. Saxena, C. Leu, J. E. Martz., J. A. Carlino, N. H. Ruddle, M. A. Palladino, L. I. Gold, and G. J. Thorbecke. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 151:1116.
15. Stevens, D. B., K. E. Gould, and R. H. Swanborg. 1994. Transforming growth factor-β1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J. Neuroimmunol. 51:77.
16. Johns, L. D., K. C. Flanders, G. E. Ranges, and S. Sriram. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factorβ1. J. Immunol. 147:17926.
17. Kuruvilla, A. P., R. Shah, G. M. Hochwald, H. D. Liggitt, M. A. Palladino, and G. J. Thorbecke. 1991. Protective effect of transforming growlh factor-β1 on autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88:2918.
18. Racke, M. K., S. Sriram, J. Carlino, B. Cannella, C. S. Raine, and D. K. McFarlin. 1993. Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β2. J. Neuroimmunol. 46:175.
19. Morris, D. R., C. A. Kuepfer, L. R. Ellingsworth, Y. Ogawa, and P. S. Rabinovitch. 1989. Transforming growth factor-β blocks proliferation but not early mitogenic signaling events in T lymphocytes. Exp. Cell. Res. 185:529.
20. Ruegemer, J. J., S. N. Ho, J. A. Augustine, J. W. Schlager, M. P. Bell, D. J. McKean, and R. T. Abraham. 1990. Regulatory effects of transforming growth factor-β on IL-2 and IL-4 dependent T cell cycle progression. J. Immunol. 144:1767.
21. Ortaldo, J. R., A. T. Mason, J. J. O'Shea, M. J. Smyth, L. A. Falk, I. C. S. Kennedy, D. L. Longo, and F. W. Ruscetti. 1991. Mechanistic studies of transforming growth factor-β inhibition of IL-2-dependent activation of CD3-large granular lymphocyte functions: regulation of IL-2Rβ signal transduction. J. Immunol. 146:3791.
22. Brabletz, T., E. Schorr, F. Siebelt, T. Wirth, and R. Serfling, 1993. Transforming growth factor-β and cyclosporin-A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol. Cell. Biol. 13:1155.
23. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240:1169.
24. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.
25. Klausner, R., and L. Samelson. 1991. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell 64:875.
26. Bolen, J. B. 1995. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr. Opin. Immunol. 7:306.
27. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
28. Robey, E., and J. P. Allison, 1995. T cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol. Today 17:306.
29. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignalling pathways and T cell function. Immunity 4:527.
30. Nakamura, Y., S. M. Russel, S. A. Mess, M. Friedman, M. Erdos, C. Francois, Y. Jacques, S. Adelstein, and W. J. Leonard. 1994. Heterodimerization of IL-2Rβ and γ chain cytoplasmic domains is required for signalling. Nature 369:330.
31. Russel, S. M., J. A. Johnston, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friedman, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, A. S. Goldman, F. C. Schmalstieg, J. N. Ihle, J. J. O'Shea, and W. J. Leonard. 1994. Interaction of IL-2Rβ and γc chains with Jak-1 and Jak-3: implications for XS-CID and XCID. Science 266:1042.
32. Witthuhn, B. A., O. Silvennoinen, O. Miura, K. S. Lai, C. Cwik, E. T. Liu, and J. N. Ihle. 1994. Involvement of the Jak-3 kinase in signalling by interleukin-2 and 4 in lymphoid and myeloid cells. Nature 370:153.
33. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z. Liu, I. Oishi, O. Silvennoinen, B. Witthuhn, J. N. Ihle, and T. Taniguchi. 1994. Functional activation of Jak-1 and Jak-3 by selective association with IL-2 receptor subunits. Science 266:1045.
34. Johnston, J. A., M. Kawamura, R. A. Kirken, Y. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2, Nature 370:151.
35. Johnston, J. A., C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, J. D. Giri, and J. J. O'Shea. 1995. Tyrosine phosphorylation and activation or Stat 5, Stat 3 and Janus kinases by IL-2 and 15. Proc. Natl. Acad. Sci. USA 92:8705.
36. Lin, J. X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. H. Leonard. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2:331.
37. Fujii, H., Y. Nakagawa, U. Schindler, A. Kawahara, H. Mori, F. Bouilleux, B. Groner, J. N. Ihle, Y. Minami, T. Miyazaki, and T. Taniguchi. 1995. Activation of Stat 5 by interleukin 2 requires a carboxylterminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 92:5482.
38. Su, X., and S. Sriram. 1992. Analysis of TCR Vβ gene usage and encephalitogenicity of myelin basic protein pcptide p91-103 reactive T cell clones in SJL mice: lack of evidence for V gene hypothesis. Cell. Immunol. 141:485.
39. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
40. Argetsinger, L. S., X. Yang, A. Witthuhn, O. Silvennoinen, J. N. Ihle, and C. Carte-Su. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237.
41. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleolidyl transfera se and nick translation assays. Cancer Res. 53:1945.
42. Espevik, T., A. Waage, A. Faxvaag, and M. R. Shalaby, 1990. Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1β and transforming growth factor-β. Cell. Immunol. 126:47.
43. Ahuja, S. S., F. Paliogianni, H. Yamada, J. E. Balow, and D. T. Boumpas. 1993. Effect of transforming growth factor-β on early and late activation events in human T cells. J. Immunol. 150:3109.
44. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massague. 1994. Mechanism of activation of the TGFβ receptor. Nature 370:341.
45. Massague, J. 1996. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85:947.
46. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993, Negative regulation of G1 in mammalian cells: inhibition of cyclin E dependent kinase by TGF-β. Science 260:536.
47. Laiho, M., J. A. D. Caprio, J. W. Ludlow, D. M. Livingston, and J. Massague, 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175.
48. kip1. a cyclin-dependent kinuse inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
49. INK4B is a potential effector of TGFβ induced cell cycle arrest. Nature 371:257.
50. Weller, M., D. B. Constam, U. Malipiero, and A. Fontana. 1994. Transforming growth factor-β2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur. J. Immunol. 24:293.
51. Boussiotis, V. A., D. L. Barber, T. Nakarai, G. J. Freeman, J. G. Gribben, G. M. Bernstein, A. D. D'Andria, J. Ritz, and L. M. Nadler. 1994. Prevention of T cell anergy by signalling through the γc chain of the IL-2 receptor. Science 266:1039.
52. Oakes, S. A., F. Candotti, J. A. Johnston, Y. Chen, J. J. Ryan, N. Taylor, X. Liu, L. Hennighausen, L. D. Notarangelo, W. E. Paul, R. M. Blaese, and J. J. O'Shea. 1996. Signalling via IL-2 and IL-4 in Jak-3 deficient severe combined immunodeficiency lymphocytes: Jak-3 dependent and independent pathways. Immunity 5:605.
53. Hunter, T. 1995. Protein kinases phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225.
54. Vogel, W., R. Lamers, J. Huang, and A. Ullrich. 1993. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259:1611.
55. Pazdrak, K., L. Justement, and R. Alarm. 1995. Mechanism of inhibition of eosinophil activation by transforming growth factor-beta: inhibition of Lyn, MAP, Jak2 kinase, and Slat I nuclear factor. J. Immunol. 155:4454.
56. Panek, R. B., Y. Lee, and E. N. Benveniste. 1995. TGF-β suppression of IFN-γ-induced class II MHC gene expression does not involve inhibition of phosphorylation of Jak-1, Jak-2, or signal transducers and activators of transcription, or modification of IFN-γ enhanced factor X expression. J. Immunol. 154:610.